ZYDUS LIFESCIENCES; Zydus receives final Approval from the USF | IIFL HDFC Securities Trading

ZYDUS LIFESCIENCES; Zydus receives final Approval from the USFDA for Doxepin Hydrochloride Capsules USP, 150 mg

Doxepin Hydrochloride Capsules USP, 150 mg had annual sales of USD 2.11 mn in the United States (IQVIA MAT Jan. 2023).